NOTIFICATION NO. 56/2021, DT. 24/02/2022
- Document type
- Circular
- Dated
Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) regarding
Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) – regarding
S.O. 846(E).—In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes following amendment in Notification No. 08/2015-20 dated 14.06.2021, Notification No. 07/2015-20 dated 01.06.2021 and Notification No. 50/2015-20 dated 10.01.2022 related to export of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API):
| Sl.No. | ITC HS Codes | Description | Existing Policy | Revised Policy |
| 207AA |
Ex 293499 Ex 300490 |
Injection Remdesivir and Remdesivir Active harmaceutical Ingredients (API) | Restricted | Free |
| 207AB |
Ex 30049029 Ex 30049099 |
Amphotericin – B Injections | Restricted | Free |
| 207AE |
Ex 2942 Ex 3001 Ex 3002 |
Enoxaparin (Formulation and API) | Restricted | Free |
| 207AF | Ex 3002 | Intra-Venous Immunoglobulin (IVIG)(Formulation and API) | Restricted | Free |
2. Effect of this Notification:
The export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API), Amphotericin – B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under HS code as mentioned above or falling under any other HS code has been made ‘Free’ with immediate effect.
SANTOSH KUMAR SARANGI,
Director General of Foreign Trade
& Ex-Officio Addl. Secy.
[F. No. 01/91/180/24/AM22/EC /E-27724]